Status:
COMPLETED
Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine
Lead Sponsor:
Cairo University
Conditions:
Spermatic Cord Block
Eligibility:
MALE
18-60 years
Phase:
EARLY_PHASE1
Brief Summary
Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minim...
Detailed Description
The technique of the spermatic cord block was first described in the 1960s by Earle AS.Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique wheth...
Eligibility Criteria
Inclusion
- Patients aged from 18 to 60 years.
- ASA I-II.
- Undergoing Testicular Sperm Extraction Surgery.
- BMI from 18.5 to 30 kg/m2
Exclusion
- Patient refusal
- Contraindications to regional anesthesia (bleeding disorders e.g. INR\>1.5, PC\<70%, platelet count\<100 × 109, use of any anti-coagulants, local infection, etc.).
- Known allergy to local anesthetics.
- ASA III-IV.
- Patients aged less than 18 or more than 60.
- Body mass index \>35.
- Patients with difficulty in evaluating their level of pain.
Key Trial Info
Start Date :
June 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 22 2021
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04498351
Start Date
June 30 2020
End Date
October 22 2021
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Cairo University.
Cairo, Egypt, 11451